HRAS Polyclonal antibody

HRAS Polyclonal Antibody for WB, IP, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, rat

Applications

WB, IP, ELISA

Conjugate

Unconjugated

Cat no : 15531-1-AP

Synonyms

C BAS/HAS, C H RAS, C HA RAS1, CTLO, GTPase HRas, H Ras 1, H RASIDX, Ha Ras, HAMSV, HRAS, HRAS1, K RAS, p21ras, RASH1, Transforming protein p21



Tested Applications

Positive WB detected inHeLa cells, PC-12 cells, MCF-7 cells
Positive IP detected inHeLa cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:1000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Sample-dependent, check data in validation data gallery

Published Applications

WBSee 2 publications below

Product Information

15531-1-AP targets HRAS in WB, IP, ELISA applications and shows reactivity with human, rat samples.

Tested Reactivity human, rat
Cited Reactivity human
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen HRAS fusion protein Ag7704 相同性解析による交差性が予測される生物種
Full Name v-Ha-ras Harvey rat sarcoma viral oncogene homolog
Calculated molecular weight 21 kDa
Observed molecular weight 21 kDa
GenBank accession numberBC006499
Gene symbol HRAS
Gene ID (NCBI) 3265
RRIDAB_2878147
Conjugate Unconjugated
Form Liquid
Purification Method Antigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Protocols

Product Specific Protocols
WB protocol for HRAS antibody 15531-1-APDownload protocol
IP protocol for HRAS antibody 15531-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Mol Med Rep

Sirtuin 2 knockdown inhibits cell proliferation and RAS/ERK signaling, and promotes cell apoptosis and cell cycle arrest in multiple myeloma.

Authors - Tianling Ding
humanWB

Naunyn Schmiedebergs Arch Pharmacol

The potential mechanism of Neu5Gc inducing colorectal cancer based on network pharmacology and experimental validation

Authors - Li-Chao Zhang